Clinical Trial Update: Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating topical 5% tranexamic acid for postinflammatory hyperpigmentation due to acne vulgaris has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postinflammatory Hyperpigmentation

Drugs mentioned

• Tranexamic acid (topical 5%) (tranexamic acid)

Snippet

Sponsor: Wayne State University | Conditions: Postinflammatory Hyperpigmentation | Phase 2, Phase 3 | Status: WITHDRAWN